The left ventricular mechanical dispersion as a marker of disease severity in transthyretin cardiac amyloidosis
Transthyretin amyloidosis (ATTR) is a fatal disorder, thus early detection of cardiac involvement is crucial for improved clinical outcomes. This study investigated the utility of left ventricular (LV) speckle-tracking-derived mechanical dispersion as a potential marker for the assessment of cardiac amyloidosis (CA) in patients with ATTR and their first-degree relatives. This prospective, single-centre study enrolled 100 adults from 2020 to 2024 (ClinicalTrials NCT05814380). Participants underwent clinical assessment, genetic testing, and [<sup>99m</sup>Tc]Tc-DPD SPECT/CT. Global longitudinal strain (GLS) and mechanical dispersion were evaluated using speckle-tracking echocardiography. Patients with ATTR CA exhibited significantly impaired GLS and increased mechanical dispersion (p < 0.001). Mechanical dispersion exhibited correlations with age, New York Heart Association class, LV mass index, E/E', LV ejection fraction, GLS, levels of N-terminal pro-brain natriuretic peptide and Perugini grade (p < 0.05 for all). In univariable Cox regression, mechanical dispersion (Hazard ratio (HR) = 1.03, 95% confidence intervals (CI) 1.01-1.06, p = 0.004), normalised to heart rate mechanical dispersion (HR = 1.43, 95% CI 1.14-1.81, p = 0.002) were significant predictors of all-cause mortality. In our study increased mechanical dispersion was associated with advanced disease stages and mortality. These findings suggest that it may serve as a marker of ATTR CA.Registration: ClinicalTrials.gov Identifier: NCT05814380.
Authors
- Krystian Mróz (ORCID: https://orcid.org/0000-0002-4884-4101)
- Andrzej Ząbek (ORCID: https://orcid.org/0000-0001-8331-3210)
- Maria Kurek
- Piotr Podolec (ORCID: https://orcid.org/0000-0001-6101-2935)
- Katarzyna Holcman (ORCID: https://orcid.org/0000-0002-6895-4076)
- Bogdan Ćmiel (ORCID: https://orcid.org/0000-0002-2284-6360)
- Magdalena Kostkiewicz (ORCID: https://orcid.org/0000-0001-9094-3202)
- Katarzyna Graczyk
- Paweł Rubiś (ORCID: https://orcid.org/0000-0002-6979-3411)
- Sylwia Szczepara
- Krzysztof Boczar (ORCID: https://orcid.org/0000-0002-1833-2404)
- Karolina Gutkowska
- Ewa Dziewięcka
- Agnieszka Stępień-Wroniecka
- Winiarczyk Mateusz
Institutions
- Jagiellonian University (PL)
- John Paul II Hospital (PL)
- AGH University of Krakow (PL)
Publication Details
- Journal
- Scientific Reports
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1038/s41598-025-26329-x
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer